Status:
COMPLETED
Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles
Lead Sponsor:
Pascoe Pharmazeutische Praeparate GmbH
Collaborating Sponsors:
Dr. Loges & Co. GmbH
Conditions:
Virus Diseases
Herpes Zoster
Eligibility:
All Genders
18+ years
Brief Summary
Chronic viral infections induce oxidative stress that can cause a number of concomitant diseases, e.g. cardio-vascular diseases or metabolic disorders. Therefore, a sufficient treatment of oxidative s...
Eligibility Criteria
Inclusion
- Due to the design of an Observational Cohort Study, no inclusion or exclusion criteria are named. The included patient group is described under "Cohort / Group".
- Observational Criteria:
- adult patients
- acute viral infection (especially herpes zoster)
- Primary Care patient
- eligible for add-on therapy with vitamin C
- willingness to provide pseudonymized data to the Sponsor
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00921934
Start Date
April 1 2009
End Date
December 1 2010
Last Update
December 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Praxis Dr. Schencking, Rheinstr. 77a
Ransbach-Baumbach, Rhineland-Palatinate, Germany, 56235